A Crossover Study to Assess the Effect of Intravenous Infusion of Piperacillin/Tazobactam on the Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) in Healthy Adult Participants
Clinical trial NCT03441529 · COMPLETED
Trial details
- NCT number
- NCT03441529
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-09
- Primary completion
- 2018-05-03
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.